First Citizens Bank & Trust’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-965
Closed -$16.6K 638
2025
Q4
$16.6K Hold
965
﹤0.01% 636
2025
Q3
$24.8K Hold
965
﹤0.01% 627
2025
Q2
$55.5K Hold
965
﹤0.01% 608
2025
Q1
$104K Hold
965
﹤0.01% 507
2024
Q4
$45.8K Buy
+965
New +$58.3K ﹤0.01% 468

Other funds holding AGL

First Citizens Bank & Trust's AGL Position: Q1 2026 in Review

First Citizens Bank & Trust sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 965 shares — an estimated $16.6K sold.

First Citizens Bank & Trust first reported a position in AGL in Q4 2024 and held it in 5 quarters. The position peaked at $104K in Q1 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • First Citizens Bank & Trust reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • First Citizens Bank & Trust sold 965 Agilon Health shares in Q1 2026, an estimated $16.6K.
  • First Citizens Bank & Trust first reported a position in Agilon Health in Q4 2024 and held it in 5 quarters.
  • First Citizens Bank & Trust's Agilon Health position peaked at $104K in Q1 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on First Citizens Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.